Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Acepodia logo — POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

Acepodia

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

Founded 2016 United States Alameda, United States 49 employees Series D Total: $256.00M Biotechnology, Health Care +1

General Information

Company Name Acepodia
Founded Year 2016
Location United States Alameda, United States +2
Founders / Decision Makers
Team member
Employees 49
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series D
Social

Get notified when Acepodia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Acepodia

Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its Antibody-Cell Conjugation (ACC) technology to link tumor-targeting antibodies to its proprietary immune effector cells, creating novel antibody cell effector (ACE) therapies. These therapies demonstrate increased binding strength against tumors expressing low levels of tumor antigens, promising a broad impact. The last Series D investment of $100.00M on 06 June 2023 was secured from Digital Mobile Venture. The company's headquarters are based in the United States. Acepodia is backed by a team of seasoned leadership and scientific experts committed to advancing its robust pipeline of off-the-shelf ACE therapies, holding great potential to benefit a wide population of patients across various solid tumors and hematologic cancers.

Taxonomy: Acepodia, clinical-stage, cancer cell immunotherapy, off-the-shelf, NK cells, antibody-cell conjugation, cell therapy, oncology, immune effector cells, solid tumors, hematologic cancers, immunotherapeutic strategies, interdisciplinary technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 1 •••• •••• 06 Jun 2023
Series C •••••• 1 •••• •••• 02 Dec 2021
Series B •••••• 4
Investor Investor Investor Investor
16 Mar 2021

Acepodia Alternatives & Competitors

Acepodia vs
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. United States

Pioneering a Multi-Antigen Approach

Grant
20 employees
Biotechnology, Health and Wellness
Compare Acepodia vs Marker Therapeutics, Inc.
Acepodia vs
Cytovia Therapeutics
Cytovia Therapeutics United States

We empower Natural Killer cells to fight cancer through stem cell engineering and multispecific anti...

Unknown
6 employees
Biotechnology, Life Sciences
Compare Acepodia vs Cytovia Therapeutics
Acepodia vs
Link Cell Therapies
Link Cell Therapies United States

A True CAR T Cell AND-Gate

22 employees
Biotechnology, Life Sciences
Compare Acepodia vs Link Cell Therapies
Also compare with: Acepodia vs Abcuro, Inc Abcuro, Inc

FAQ About Acepodia

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Acepodia was founded in 2016.
Acepodia is headquartered in Alameda, United States.
Acepodia operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Acepodia has approximately 49 employees.
Acepodia has completed 3 funding rounds, raising a total of $256.00M. The latest funding stage is Series D.
Top alternatives and competitors to Acepodia include Marker Therapeutics, Inc., Cytovia Therapeutics, Link Cell Therapies, Compass Therapeutics Inc., Abcuro, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acepodia and Marker Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Acepodia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy